In situ formed double network hydrogel dressing and preparation method and application thereof

Through the dual network hydrogel composed of tilapia skin gelatin and brown algae fucoidan, the problem of poor stability of traditional hydrogels is solved, rapid gelation and antioxidant performance are improved, and wound healing process is significantly promoted. .

CN116870241BActive Publication Date: 2024-11-08HAINAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310968401.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-08-03
Publication Date
2024-11-08
Estimated Expiration
2043-08-03

AI Technical Summary

Technical Problem

Traditional single network hydrogels have poor stability in complex physiological environments, are difficult to effectively promote wound healing during wound healing, and lack good biocompatibility and antioxidant properties.

Method used

A double network hydrogel composed of tilapia skin gelatin and brown algae fucoidan is constructed through catalytic cross-linking of H2O2 and HRP to form a hydrogel dressing with controllable gelation time and good biocompatibility.

Benefits of technology

Hydrogel dressings with rapid gelation, enhanced stability, excellent antioxidant properties and good biocompatibility are achieved, significantly accelerating the wound healing process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116870241B_ABST
    Figure CN116870241B_ABST
Patent Text Reader

Abstract

The present invention discloses an in-situ formed double network hydrogel dressing and its preparation method and application. The double network hydrogel dressing is constructed by mixing H2O2 (hydrogen peroxide), HRP (horseradish peroxidase), Tsg-Tyr (tilapia skin gelatin-tyramine) and FucC-Tyr (carboxylated fucoidan-tyramine) in Aga (agarose), and utilizing the catalytic crosslinking of HRP / H2O2 and the sol-gel transformation of Aga. The TF double network hydrogel has rapid and adjustable gelation, and the addition of Aga further enhances the stability of the hydrogel. The good three-dimensional mesh structure of the TF double network hydrogel will be beneficial to the exchange of nutrients at the wound. In addition, the TF double network hydrogel exhibits excellent antioxidant properties and biocompatibility in vitro. At the same time, in the in vivo full-thickness wound healing experiment, the TF double network hydrogel can effectively accelerate wound healing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomedical materials, and in particular to an in-situ formed double network hydrogel dressing and a preparation method and application thereof. Background Art

[0002] In real life, the skin is extremely vulnerable to injuries such as burns and abrasions, which destroy the integrity of the skin and affect the normal life of the human body. If these injuries are not treated in time, they may cause deep damage to the skin tissue, form chronic wounds, and further affect human health. To date, various wound dressings including membranes, hydrocolloids and hydrogels have been widely developed and utilized. Traditional wound dressings can serve as a barrier to the external environment of the wound to protect the wound from external influences. However, suitable wound dressings should have good biocompatibility, maintain a moist wound environment, and have excellent biological effects such as anti-oxidation in order to show better therapeutic effects in wound healing.

[0003] Gelatin is a natural polymer obtained by partial hydrolysis of collagen. It has good biodegradability and biocompatibility in physiological environments. Currently, gelatin has been used as a biomedical material in fields such as bone repair and wound repair. However, single-network hydrogels may show poor stability in complex physiological environments. Summary of the invention

[0004] In response to the technical problems existing in the prior art, this article provides an in situ formed double-network hydrogel dressing and its preparation method and application. The hydrogel wound dressing composed of tilapia skin gelatin (Tsg) and brown algae fucoidan (Fuc) has a controllable gelation time and good biocompatibility, and can promote wound healing.

[0005] The technical solution adopted by the present invention to achieve the technical purpose is:

[0006] The invention provides an in situ formed double network hydrogel dressing, which is constructed by mixing H2O2 (hydrogen peroxide), HRP (horseradish peroxidase), Tsg-Tyr (tilapia skin gelatin-tyramine) and FucC-Tyr (carboxylated fucoidan-tyramine) in Aga (agarose), and utilizing the catalytic crosslinking of HRP / H2O2 and the sol-gel transition of Aga.

[0007] The present invention also provides a method for preparing an in situ formed double network hydrogel dressing, comprising: dissolving H2O2 and HRP in an Aga solution respectively, and then adding them to an Aga mixed solution containing Tsg-Tyr and FucC-Tyr respectively, vibrating the mixture to form a gel, and then keeping it at a low temperature to obtain a TF double network hydrogel.

[0008] Preferably, the Aga solution is prepared by the following method: dissolving Aga in deionized water to obtain a 1% (w / v, mass volume ratio, unit: g / mL) Aga solution, and then cooling it for use.

[0009] Preferably, the concentration of H2O2 in the Aga solution is 0.02-0.1 mmol / mL, more preferably 0.02, 0.04, 0.06, 0.08 and 0.1 mmol / mL; the concentration of HRP in the Aga solution is 0.1-0.5 mg / mL, more preferably 0.1, 0.2, 0.3, 0.4 and 0.5 mg / mL.

[0010] Preferably, the concentrations of the Aga mixed solution containing Tsg-Tyr and FucC-Tyr are 0%, 3%, 5%, 7% and 9% (w / v, mass volume ratio, unit g / mL), wherein Tsg-Tyr:FucC-Tyr=1:1 (w / w).

[0011] Preferably, the volume ratio of the Aga solution containing H2O2 and HRP dissolved therein and the Aga mixed solution containing Tsg-Tyr and FucC-Tyr is 1:4.

[0012] Preferably, after the gel is formed, it is kept at 2-8° C. for 24 hours to obtain the TF double network hydrogel.

[0013] Preferably, Tsg-Tyr is prepared by the following method:

[0014] 1-1) Tsg is suspended in an aqueous solution of MES (morpholineethanesulfonic acid) and heated. After Tsg is dissolved, the solution is cooled.

[0015] 1-2) Tyr, EDC and NHS are added to the cooled solution of step 1-1), and after stirring, the synthesized polymer solution is dialyzed. The sample is then freeze-dried to obtain the product Tsg-Tyr.

[0016] More preferably, in step 1-1), the mass volume ratio (g / mL) of Tsg to the MES (morpholineethanesulfonic acid) aqueous solution is 1:50; and / or the molar concentration of the MES (morpholineethanesulfonic acid) aqueous solution is 50 mM.

[0017] More preferably, in step 1-2), the weight ratio of Tyr, EDC and NHS is 1:0.73:0.22, and the mixture is stirred at 25°C for 12 hours.

[0018] Preferably, FucC-Tyr is prepared by the following method:

[0019] 2-1) Add Fuc to NaOH and isopropanol solution, place in an ice bath, and stir to form a uniform suspension.

[0020] 2-2) slowly dripping a mixture of chloroacetic acid and NaOH in isopropanol into the reaction system of step 2-1) and gradually raising the temperature.

[0021] Stir, stop the reaction, cool to room temperature, adjust pH to neutral. After dialysis, rotary evaporate the solution, freeze-dry,

[0022] Carboxymethylated fucoidan (FucC) was obtained.

[0023] 2-3) FucC was dissolved in distilled water, and then EDC and NHS were added, and the pH of the solution was adjusted to 5.5-6.5. The mixture was stirred at room temperature, and then Tyr was added. Subsequently, the reaction was stirred at 25°C for 2 days and dialyzed with deionized water. Finally, freeze-dried to obtain the product FucC-Tyr.

[0024] More preferably, in step 2-1), 10 mL of 20% NaOH (w / v) and 25 mL of isopropanol solution are added per 120 mg of Fuc.

[0025] More preferably, in step 2-2), the isopropanol mixture containing chloroacetic acid and NaOH is prepared by dissolving 3 g of chloroacetic acid and 10 mL of 20% (w / v) NaOH in every 25 mL of isopropanol, the volume ratio of the mixture to the reaction system is 1:1, the temperature is raised to 60° C., and the stirring time is 3 h.

[0026] More preferably, in step 2-3), the weight ratio of FucC, EDC, NHS and Tyr is 1:1.8:1:4.

[0027] The present invention further provides use of the double-network hydrogel dressing in preparing a product for improving full-thickness wound healing.

[0028] The above technical solution of the present invention has the following advantages:

[0029] The TF double network hydrogel prepared by the present invention has rapid and adjustable gelation, and the addition of Aga further enhances the stability of the hydrogel. The good three-dimensional mesh structure of the TF double network hydrogel will be beneficial to the exchange of nutrients at the wound. In addition, the TF double network hydrogel exhibits excellent antioxidant properties and biocompatibility in vitro. At the same time, in the in vivo full-thickness wound healing experiment, the TF double network hydrogel can effectively accelerate wound healing. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 is an appearance diagram of a hydrogel dressing according to an embodiment of the present invention;

[0031] Figure 2 is a gel time test chart of Test Example 1 of the present invention;

[0032] Figure 3 This is a SEM image of the hydrogel dressing of Test Example 2 of the present invention;

[0033] Figure 4 This is a test diagram of the mechanical properties of the hydrogel dressing of Test Example 3 of the present invention;

[0034] Figure 5 This is a diagram showing the antioxidant effect of the hydrogel dressing of Test Example 4 of the present invention;

[0035] Figure 6 This is a cell compatibility test diagram of the hydrogel dressing of Test Example 5 of the present invention;

[0036] Figure 7 This is a diagram of a wound treated with the hydrogel dressing of Test Example 6 of the present invention. DETAILED DESCRIPTION

[0037] In order to make the technical solutions and functional features of the present invention more clear, the technical solutions of the present invention will be further fully described in the embodiments in conjunction with the accompanying drawings.

[0038] In the present invention, "room temperature" may be "25°C±5°C".

[0039] Example 1

[0040] The present invention provides a method for preparing an in-situ formed double network hydrogel dressing, comprising the following steps:

[0041] 1. Grafting tyrosine modification of Tsg: 2 g of Tsg was suspended in 100 mL of morpholineethanesulfonic acid solution (50 mM), heated to dissolve, and then the solution was cooled to room temperature. 1 g of Tyr, 0.73 g of EDC, and 0.22 g of NHS were added to the solution, and after stirring at 25 ° C for 12 h, the polymer solution was dialyzed (MW: 3500), and the sample was subsequently freeze-dried to obtain the product Tsg-Tyr.

[0042] 2. Grafting tyrosine modification of Fuc: First, carboxymethylate the fucoidan. Weigh 120g of fucoidan, add 10mL of 20% NaOH (i.e., mass concentration 20g / 100mL) and 25mL of isopropanol solution, place in an ice bath, and stir to make a uniform suspension. Slowly drip the mixed solution into the reaction system, gradually heat it to 60°C, stir, cool it to room temperature, adjust the pH to 7, dialyze, and rotary evaporate the solution. Frozen and dried to obtain carboxymethylated fucoidan (FucC). Dissolve 0.50g of FucC in 100mL of distilled water, then add 0.90g of EDC and 0.50g of NHS, and adjust the pH to 5.5-6.5. Stir the mixture at room temperature for 30min, and then add 2g of Tyr. Subsequently, stir at 25°C for 2 days. After dialysis in deionized water (MW: 3500) for 48h, freeze-dry the dialysate to obtain the product FucC-Tyr.

[0043] 3. Dissolve 1g Aga in 100mL deionized water and cool to 50℃ before use. Use the above Aga solution to prepare H2O2 solutions and HRP solutions of certain concentrations. The H2O2 concentrations are 0.02, 0.04, 0.06, 0.08 and 0.1mmol / mL, and the HRP concentrations are 0.1, 0.2, 0.3, 0.4 and 0.5mg / mL.

[0044] 0.05 mL of each of the prepared Aga solutions containing H2O2 and HRP were added to 0.2 mL of Aga solutions containing Tsg-Tyr and FucC-Tyr at concentrations of 0%, 3%, 5%, 7% and 9% w / v (unit g / mL, corresponding to 0 g, 3 g, 5 g, 7 g and 9 g of Tsg-Tyr / FucC-Tyr per 100 mL Aga solution), Tsg-Tyr:FucC-Tyr = 1:1 (w / w, mass ratio), and the mixture was vibrated to quickly form a single network hydrogel. Subsequently, the mixture was kept at 2-8°C for 24 hours to obtain a double network hydrogel (TF). According to the initial concentrations of the mixture of Tsg-Tyr and FucC-Tyr of 0%, 3%, 5%, 7% and 9% w / v, the obtained hydrogels were named Aga, TF-3, TF-5, TF-7 and TF-9 hydrogels, respectively.

[0045] The appearance of the hydrogel dressing prepared above is as follows Figure 1 As shown in the figure, TF-9 hydrogel is in a transparent colloidal state and has a good gel system.

[0046] Test Example 1 Gel Time Test

[0047] The effects of HRP (0.1, 0.2, 0.3, 0.4 and 0.5 mg / mL), H2O2 (0.02, 0.04, 0.06, 0.08 and 0.1 mmol / mL) and polymer concentration (0%, 3%, 5%, 7% and 9% w / v) on gelation time were tested. According to the above-mentioned TF hydrogel preparation method, we used the inversion method, and the absence of flow within 60 seconds after tilting the centrifuge tube was considered to be in a gel state, and the gelation time was recorded to measure the change in the gelation time of the hydrogel.

[0048] The results are as follows Figure 2 As shown in the figure, when the polymer concentration is 9%, the gel time is only 4s, which will be very beneficial for emergency treatment of complex wound environments. This is mainly due to the increase in the content of phenolic groups in the polymer, which promotes the covalent cross-linking reaction between hydrogels.

[0049] Test Example 2 Scanning Electron Microscope Test

[0050] The pore morphology of the TF-9 hydrogel was observed using a scanning electron microscope, and the hydrogel was prepared according to Example 1. The freeze-dried sample was used to obtain an internal cross-section, and then a thin layer of gold was sputtered for internal morphology studies.

[0051] The experimental results are as follows Figure 3 As shown in the figure, TF-9 hydrogel has a more stable three-dimensional mesh structure and a more uniform pore structure compared to the original Tsg, which may be beneficial for the absorption of wound exudate and hemostasis.

[0052] Test Example 3 Mechanical Properties Test

[0053] The mechanical properties of each group of hydrogels were analyzed using a material tester (Instron 3343, Instron, USA).Compression tests were performed on cylindrical hydrogels placed between metal plates.

[0054] The experimental results are as follows Figure 4 As shown in Figure 3, the results show that the compressive strength of TF hydrogels gradually increases with the increase in polymer concentration. These enhanced mechanical properties may be due to the increase in phenolic groups in the polymers and the increase in the degree of covalent cross-linking between polymers.

[0055] Test Example 4 Antioxidant Performance Test

[0056] The antioxidant properties of each group of hydrogels were evaluated by scavenging DPPH free radicals. The hydrogels were cut into homogenates using a tissue grinder. Then DPPH and the hydrogel homogenate were dispersed in ethanol, with PBS as the blank group. After mixing, the mixture was incubated in the dark. The absorbance of the mixture was measured by UV-visible spectroscopy. The calculation formula for DPPH scavenging rate is as follows:

[0057]

[0058] Where As is the sample absorbance and Ac is the control absorbance.

[0059] The experimental results are as follows Figure 5 As shown, the antioxidant capacity of TF hydrogels will promote their application in the complex environment of wounds and increase their potential for application in wound treatment.

[0060] Test Example 5 Cytocompatibility test of hydrogel dressing

[0061] The cell compatibility experiment was conducted using mouse embryonic fibroblasts (NIH 3T3) using the MTT method. NIH-3T3 cells were cultured in a normal culture medium. After 24 hours, the original culture medium was replaced with a culture medium containing different concentrations of TF-9 hydrogel extracts and continued to be cultured. The proliferation of each group of cells was measured by the MTT method on the first and third days.

[0062] The results are as follows Figure 6 As shown, the results showed that TF-9 did not affect the metabolic activity of NIH-3T3 cells and had good cell viability.

[0063] Test Example 6 Animal Wound Healing Test

[0064] The wound repair performance of the hydrogel was evaluated using a rat back full-thickness skin defect model. The wound dressing made of the prepared hydrogel was placed on the skin defect site. The skin defect site of the control group rats was not treated (Group C), the positive control group was Group P, and the TF-9 treatment group was Group Y. Photos of the wound site were taken and recorded on days 0, 4, 8, and 12. The experimental results are shown in the figure. Figure 7 shown.

[0065] The results showed that the wounds in group Y recovered faster than those in groups C and P, and the wounds were almost completely healed on the 12th day.

[0066] Obviously, the above embodiments of the present invention are merely examples to more clearly illustrate the present invention, and are not limitations on the implementation methods of the present invention. For ordinary technicians in the relevant field, other different forms of changes or modifications can be made on the basis of the above description. It is impossible to list all the implementation methods here. All obvious changes or modifications derived from the technical solution of the present invention are still within the protection scope of the present invention.

Claims

1. A method for preparing an in situ formed double network hydrogel dressing, characterized in that: The steps include: The first step is the grafting tyramine modification of Tsg: 2 g of Tsg was suspended in 100 mL of 50 mM morpholineethanesulfonic acid solution, and after heating to dissolve, the solution was cooled to room temperature; 1 g of Tyr, 0.73 g of EDC and 0.22 g of NHS were added to the solution, and after stirring at 25°C for 12 h, the polymer solution was dialyzed, and the sample was subsequently freeze-dried to obtain the product Tsg-Tyr; The second step is the grafting tyramine modification of Fuc: First, the fucoidan is carboxymethylated, 120g of fucoidan is weighed, 10mL of 20% NaOH, i.e., NaOH with a mass concentration of 20g / 100mL and 25mL of isopropanol solution are added, and a uniform suspension is prepared after ice bath and stirring; the mixed solution is slowly dripped into the reaction system, the temperature is raised to 60°C, stirred, cooled to room temperature, the pH is adjusted to 7, the solution is rotary evaporated after dialyzation, and freeze-dried to obtain carboxymethylated fucoidan FucC; 0.50g of FucC is dissolved in 100mL of distilled water, and then 0.90g of EDC and 0.50g of NHS are added to adjust the pH to 5.5-6.5; the mixture is stirred at room temperature for 30min, and then 2g of Tyr is added; subsequently, it is stirred at 25°C for 2 days; after dialysis in deionized water for 48h, the dialyzate is freeze-dried to obtain the product FucC-Tyr; The third step is to dissolve 1g Aga in 100mL deionized water and cool it to 50℃ for use; use the above Aga solution to prepare H2O2 solution and HRP solution of certain concentrations, the H2O2 concentrations are 0.02, 0.04, 0.06, 0.08 and 0.1mmol / mL, and the HRP concentrations are 0.1, 0.2, 0.3, 0.4 and 0.5mg / mL, respectively; add 0.05mL of the prepared Aga solution containing H2O2 and HRP to 0.2mL of Aga solution containing Tsg-Tyr and FucC-Tyr at a concentration of 9% w / v, TsgTyr:FucC-Tyr=1:1 w / w, and vibrate the mixture to quickly form a single network hydrogel; then, keep it at 2-8℃ for 24h to obtain a double network hydrogel.

2. Use of the double network hydrogel dressing prepared by the preparation method of the in situ formed double network hydrogel dressing according to claim 1 in products for improving full-thickness wound healing.